It’s a question that has enthralled scientists for decades: How can we extend life expectancy, giving humans everywhere more years of good health?
This field is known as longevity science, and within this industry experts argue that cures that treat aging as a normal but treatable disease are rare, and of the available approaches, only those who have a high level of education and are privileged.
Just a few of the key principles that govern this approach to medicine include therapeutics, personalized medicine, predictive diagnostics, and artificial intelligence. The goal is to eliminate a “one-size-fits-all” attitude toward treatment and ensure that therapies are tailored to a person’s unique medical profile. This can matter in many different ways: the best way to deal with cancer, the foods we eat, and our risk of heart disease.
And while predictive diagnostics offers an existing way to unlock better patient outcomes, this often depends on using large amounts of anonymized data to determine what has happened in the past and how to achieve greater levels of success in the future.
Interestingly, there are parallels between cryptocurrencies and the science of longevity. One could argue that this approach to medicine is currently where digital assets were in 2013, a time when crypto discussion was limited to online message boards, niche group chats, and convoluted white papers. Longevity researchers are excited to share their findings with each other, and collaboration is occurring across a number of sectors. Experts are ready to ensure that anyone interested in this nascent field can participate and contribute.
Educate the masses
As in the crypto industry, a big challenge facing the science of longevity is education, and simply explaining this concept to the public. This is a journey that requires time, effort, money and patience.
For this reason, a dedicated event has been established so that this cutting-edge concept can be discussed in an open forum. The Longevity Investor Conference will take place in Switzerland from September 28 to 30. It is sponsored by Credit Suisse and tickets can be paid for in cryptocurrency.
It is organized by Marc P. Bernegger. He is a founding partner of Maximon, a Swiss company that invests and builds companies focused on longevity. Bernegger explored Bitcoin in 2012 and told Cointelegraph, “There’s room for everyone. We can all walk the same path but take different approaches. It’s still the same narrative.”
Just some of the items on the agenda include exploring the scientific meaning of longevity, and how this will affect individuals around the world in the long term. They will also discuss how to cultivate investment in this nascent space, and according to Bernegger, this is a field of great interest to crypto enthusiasts.
The conference aims to build bridges and highlight how scientists play a vital role in ensuring that we can all benefit from longer lives and a healthy retirement. Although there are business opportunities to be found, investors face a challenge because they do not come from a scientific background. Similarly, brilliant minds often need an entrepreneurial perspective to bring their brilliant concepts to market.
Bernegger added: “There are a number of different perspectives: entrepreneurs, scientists, investors who bring money. They need a combination of everything. This sector appreciates new players. The more money there is, the more smart people and you’re serious. , better. The industry is still finding itself. It’s accessible now and people are happy to help.”
Why crypto is a good match
It is the scientific element that attracts early adopters of cryptocurrency to this space. The reason is simple: because many of these enthusiasts are forward-looking, open-minded and technology-driven.
Describing the early days of cryptography, Bernegger explained: “Everybody was in favor of the technology. It wasn’t just speculative. They saw the potential for a peer-to-peer solution, and now they see the potential for ‘aging’.
In fact, blockchain technology also has the potential to improve longevity research. Decentralized Autonomous Organizations (DAOs) have already been established that are funding research to support and commercialize therapeutics. This approach also ensures that donors can vote on the future direction of research projects.
While the bear market has cast a long shadow over the crypto sector, many in the industry are firmly in the “BUIDL” phase. They use this opportunity to innovate, cultivate new products and develop the trends that will drive the next bullfight. The science of longevity may be one of them, and according to Bernegger, pioneers know that paying close attention to health is far more important than the value of any testimony.
We already know that the rate of aging can be controlled, to some extent, by genetic pathways and biochemical processes. But in the coming decades, there are still many questions to be answered, and dots to be connected, in the quest to improve our quality of life and ensure that everyone can access it.
The Longevity Investors Conference says attendance will be strictly limited to 100 hand-picked delegates, who will be able to benefit from the insights of more than 30 keynote speakers. It’s an exciting opportunity to learn the industry inside and out, while making meaningful connections with the best people in the field.
It will take place in Gstaad, one of Switzerland’s most exclusive mountain resorts, in a “unique setting” within a luxurious five-star hotel, and top-class speakers who want to attend and present. This includes members of the Longevity Science Foundation Visionary Board.. This nonprofit organization recently entered into a partnership with The Giving Block, tapping into a vital stream of cryptophilanthropy.
If you want to know how to add years to your life and life to your years, this might be the most important conference you attend.
Exemption from liability. Cointelegraph does not endorse any content or products on this page. While our goal is to provide you with all the important information we could obtain, readers should do their own research before taking any action related to the company and take full responsibility for their decisions, and this article cannot be considered as investment advice.
